Article, News
Global Victoria HealthTech Talks – Regenerative Medicine
Victoria has a mature, internationally recognised and thriving ecosystem that supports research and translation of new Regenerative Medicine therapeutics for global markets. The field of…
Article, News
Prescient Therapeutics seeks to provide new tools for clinicians in combating cancer
The prestigious International Society of Cell and Gene Therapy (ISCT) will showcase two abstracts from Prescient Therapeutics Ltd (ASX:PTX) at its annual meeting in Paris, which runs…
Article, News
Dan Shelly, PhD, on Developing an Allogeneic, Adaptable CAR Platform
We can profile the patient, find out what they need, we pull the appropriate targeting ligand from the freezer, couple it to the cell we…
Article, News
Prescient bolsters board, abstracts showcased at prestigious conference
Clinical stage oncology company Prescient Therapeutics (ASX: PTX) has appointed highly experienced US biotech executive Dr Ellen Feigal as a Non-Executive Director of PTX. Dr…
Article, News
Prescient Therapeutics to present OmniCAR and CellPryme abstracts at international gene therapy conference
Clinical stage oncology company Prescient Therapeutics (ASX: PTX) will present two of its abstracts at an annual conference of the International Society of Cell & Gene Therapy…
Article, News
Prescient Therapeutics to present CellPryme and OmniCAR data to International Society of Cell and Gene Therapy
The prestigious International Society of Cell and Gene Therapy (ISCT) will showcase two abstracts from Prescient Therapeutics Ltd (ASX:PTX) at its annual meeting in Paris, which runs…
Article, News
Prescient Therapeutics (ASX:PTX) announces US-based Dr Ellen Feigal as new inclusion to Board
ASX-listed clinical-stage oncology company Prescient Therapeutics (ASX: PTX) has informed about the appointment of Dr Ellen Feigal to PTX’s Board. Notably, Dr Feigal is an…
Article, News
Prescient Therapeutics bolsters board with appointment of experienced US-based pharma executive
Prescient Therapeutics Ltd (ASX:PTX) has strengthened its board through the appointment of experienced pharma executive Dr Ellen Feigal as a US-based independent, non-executive director, effective today….
Article, News
Prescient Therapeutics (ASX:PTX) makes progress in March 2023 quarter
Prescient Therapeutics (ASX: PTX), the Australian listed entity into clinical stage oncology, has released its Activities Report for the quarter ended March 2023. Aside from…
Article, News
Three life sciences stocks that may be undervalued
Life science stocks have suffered heavily in 2022 due to investors shifting out of risk assets, resulting in a bear market for biotech and medical…
RECENT POSTS
Categories
- Article (102)
- Media (6)
- News (295)
- Uncategorized (1)
- Webcast Video (7)